The global implantable collamer lens market size is estimated at USD 330.5 million by 2024. As minimally invasive surgery becomes more popular, ICLs are in high demand. The future outlook for the ICL market is projected to increase by 13.2% between 2024 and 2034. A market value of USD 1,141.80 million is expected by 2034.
| Attributes | Key Insights |
|---|---|
| Implantable Collamer Lens Market Size in 2024 | USD 330.5 million |
| Projected Market Value in 2034 | USD 1,141.80 million |
| Value-based CAGR from 2024 to 2034 | 13.2% |
Explore FMI!
Book a free demo
An implantable collamer lens consists of a specially engineered biomaterial called Collamer that is biocompatible and safe. Implantable collamer lenses will remain in place for the long term, thus removing the need for glasses or contacts for long periods. From 2019 to 2023, a CAGR of 22.7% was recorded in the implantable implantable collamer lens market.
As awareness and access to ICL surgery are increased, this vision correction option is likely to become more popular. ICLs are set to become increasingly popular as people become aware of their advantages, even if they cannot qualify for traditional laser vision correction procedures.
The market for these lenses is expected to grow in the future as long as regulatory approvals continue and ICL technology advances. In the future, there are anticipated to be new models and indication ICL devices approved, with new manufacturers entering the market. This will provide patients with a greater variety of options. Based on the projections, the CAGR is expected to reach 13.2% between 2024 and 2034.
| Historical CAGR from 2019 to 2023 | 22.7% |
|---|---|
| Forecast CAGR from 2024 to 2034 | 13.2% |
Regional variations in ICL adoption can be seen in the table below giving an overview of how the market is trending in each of the countries. Major ICL manufacturers in many countries focus on high-quality materials and integrated technologies.
Forecasts indicate growth in United States, Spain, Germany, Italy and the United Kingdom. On a global scale, North America is expected to become a key industry. The next largest market is Southern Europe, followed by the rest of the world. The economic growth of emerging economies is creating new markets for ICLs.
Forecast CAGRs from 2024 to 2034
| Countries | Value CAGR |
|---|---|
| The United States | 19.8% |
| United Kingdom | 12.8% |
| Germany | 14.8% |
| Italy | 15.5% |
| Spain | 17.5% |
ICLs, or implantable collamer lenses, are becoming one of the most popular vision correction options in the United States. Technological advancement and minimally invasive surgeries to create a market for ICL’s in United States.
The market is forecast to expand at a CAGR of 19.8% over the next few decades. As more patients seek long-term vision correction solutions, ICLs are steadily gaining in popularity in the United States.
In the wake of advances in technology and better surgical techniques, ICLs have become a good option for people looking to improve their quality of life.
ICLs are increasingly being adopted in the United Kingdom as more people seek advanced vision solutions. ICLs are poised for mainstream adoption in the United Kingdom, as surgical techniques and awareness continue to advance. United Kingdom will contribute 12.8% CAGR during the next ten years.
Reimbursement policies by insurance companies for ICL implantation surgery to drive demand in next few years. A growing amount of medical tourism in the country will likely boost sales of implantable collamer lenses in the coming years. Increasing infrastructure development and high quality practitioners will drive the demand for the market.
Germany is anticipated to expand at a CAGR of 14.8% during the forecast period. The market for pain-free procedures is experiencing a surge in popularity among consumers who are becoming aware of the benefits. Regulations on the safety and efficacy of ICLs, impacting market approval processes are expected to play a major role.
Stringent quality control and sterilization standards for ICL manufacturing is expected to boost the market. In June 2022, the German Commission on Refractive Surgery (KRC) will released its guidelines for ICL implantation, including guidelines for myopia and astigmatism between 1.0 D and +1.0 D. Regulations on product liability for medical devices like ICLs are expected to increase demand.
Among the options available for achieving youthful and natural vision, implantable collamer lenses have grown in popularity in Spain over the past few years. In addition to offering clear vision, ICLs preserve the aesthetics and integrity of the eye as they do not alter the natural curvature of the cornea. They are particularly popular among women who value beauty and vitality.
The combination of vision correction and youthful appearance is particularly appealing to those who are searching for vision correction solutions. In addition to enjoying crisp, natural vision, people in Spain can also enjoy outstanding comfort and aesthetics with ICLs. A 17.5% CAGR is forecasted for Spain between 2024 and 2034.
With an appreciation for craftsmanship and meticulousness, implantable collamer lenses are highly valued in Italy. ICLs offer tailor-made correction with unique visual needs, as they value aesthetics and design. Rising disposable income and increasing patient demand for elective vision correction procedures to expand the market.
The market for implantable collamer lenses in Italy is expected to expand at a CAGR of 15.5%. ICLs offer precise and customized correction for refractive errors, including astigmatism and high myopia, in a world where high-quality vision enhancement options are highly sought-after.
Detailed information about the leading segment can be found in the following section. Based on the end user, the hospital segment held 52.4% market share in 2023. Based on indication, the myopia segment accounted for a market share of 78.2% in 2023.
| Category | Market Share 2023 |
|---|---|
| Myopia | 78.2% |
| Hospital | 52.4% |
Based on indications, myopia is likely to show prominent growth for implantable collamer lenses in the market. Across the globe, eye health problems like myopia are on the rise, along with glaucoma, cataracts, and retinal damage.
As myopia prevalence increases, implantable collamer lenses (ICLs) are expected to become more popular as a treatment option. As ICLs grow in popularity, innovations in their materials, designs, and applications can contribute to their predictability, efficacy, and safety.
Innovators are developing new products like the EVO Visian ICL for correcting super-high myopia, which will increase demand for ICLs.
Based on end users, the hospital segment is likely to grow the demand for ICL. Assuring the safety and control of ICL surgeries, hospitals provide the necessary infrastructure and facilities.
After surgery, hospitals monitor the patients' progress as part of following up with them and performing regular checks to ensure the ICL is functioning properly. The hospital plays an important role in informing patients about the advantages, dangers, and potential side effects of ICL surgery. In order to make informed decisions, they provide patients with information.
Support and guidance are provided by hospitals in the case of difficulties or post-surgery symptoms such as pressure, blurred vision, or possible infection indicators.
A highly competitive environment fosters innovation, with companies concentrating their efforts on advanced lens materials, and customized designs. Strategies for new entrants to focus on niche markets. Mergers and acquisitions in the ICL market to expand the market further.
Some of the key developments are:
| Attributes | Details |
|---|---|
| Estimated Market Size in 2024 | USD 330.5 million |
| Projected Market Valuation in 2034 | USD 1,141.80 million |
| Value-based CAGR 2024 to 2034 | 13.2% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in USD million |
| Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia; East Asia; The Middle East and Africa |
| Key Market Segments Covered | Indication, End User, Region |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC Countries, South Africa, Israel |
| Key Companies Profiled | STAAR Surgical; Alcon; Carl Zeiss Meditec; Johnson & Johnson; Bausch +Lomb |
The market is estimated to be worth USD 330.5 million in 2024.
Market size is projected to reach USD 1,141.80 million by 2034.
A 13.2% CAGR is projected for the implantable collamer lens market between 2024 and 2034.
Myopia is expected to be the largest segment in the market.
United States is expected to lead the market with 19.8% CAGR.
The market is classified into Myopia, Hyperopia and Astigmatism.
The report consists of key sourcing such as hospitals, ophthalmic clinics, ambulatory surgical centers, eye research institutes.
Analysis of the market has been undertaken in major markets of North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe, and Middle East & Africa.
Acrylic Teeth Market Trends and Assessment for 2025 to 2035
Bariatric Beds Market Analysis and Forecast for 2025 to 2035
Atypical Hemolytic Uremic Syndrome (aHUS) Treatment Market Growth and Analysis: 2025 to 2035
Retinal Vein Occlusion Treatment Market - Outlook 2025 to 2035
Klinefelter Syndrome Therapeutics Market - Growth & Demand 2025 to 2035
Veterinary Disinfectant for Pets and Farms Market - Outlook 2025 to 2035
Implantable Collamer Lens Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
